Bosutinib Related Compounds & Impurities

Bosutinib is a second-generation BCR-ABL/Src kinase inhibitor used for chronic myeloid leukaemia resistant or intolerant to prior therapy.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Bosutinib reference standards, pharmacopeial and non-pharmacopeial Bosutinib impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Bosutinib-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Bosutinib
Bosutinib Impurity 8
Bosutinib Didesmethyl TriHydrochloride Impurity
2,4-Dichloro-5-methoxyaniline
Bosutinib N-oxide
N-Desmethyl Bosutinib
Bosutinib 4-Chloro 7-Chloropropoxy Impurity
Bosutinib Impurity 8
Bosutinib 4-Hydroxy 7-Chloropropoxy Impurity
Bosutinib Chloro Impurity
4-(2,4-Dichloro-5-methoxyphenylamino)-7-hydroxy-6-methoxyquinoline-3-carbonitrile
4-(2,4-Dichloro-5-methoxyphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile
Bosutinib (Form-R)
Bosutinib Desmethyl Impurity
Bosutinib dimer impurity
Bosutinib Regio isomer impurity
Bosutinib Monohydrate
Bosutinib Didesmethyl Impurity
7-(3-Chloropropoxy)-6-methoxy-4-(4-methyl piperazin-1-yl)quinolone-3-carbonitrile
Bosutinib Nitroso Impurity
7-(3-Chloropropoxy)-4-((2,4-dichloro-5-methoxyphenyl)nitrosoamino)-6-methoxyquinoline-3-carbonitrile
Bosutinib Impurity II
Bosutinib Des NMP Impurity
N-Nitroso N-Desmethyl Bosutinib
N-Nitroso Bosutinib Impurity II
Bosutinib Impurity 31
Bosutinib Impurity 12
Bosutinib Dimer Impurity 2
Bosutinib Impurity 13
Bosutinib Propoxy Dimer Impurity
Bosutinib N-Oxide Impurity 2
Bosutinib N-Oxide Impurity 3
Bosutinib Impurity 2
Bosutinib Impurity 3
Bosutinib Impurity 4
Bosutinib Impurity 5
Bosutinib Impurity 6
Bosutinib Impurity 7
Bosutinib Impurity 1
Brigatinib Impurity 4

Isotope Labelled Compounds

Bosutinib D8
Bosutinib D9